Hi Triage, I think you are right about colonoscopy being used as frontline detection in the US way more than in OZ. The big difference is that in the US, the market is driven by private payers (insurers). If my research to date is right, reimbursement can be up to $400. And you have identified the problem too - those that charge for colonoscopies lose revenue. On the other hand, insurers and hospitals would seem to benefit hugely as do path labs from a simple blood test with such high sensitivity and specificity at a cost of $50. Maybe in the end it is GP's who drive adoption?
You also mention that FIT costs $100. I think you can buy a test in a pharmacy for $40-50 so guessing COGS is around $20 - govt. bulk purchasing would be much cheaper probably. Add administrative costs like database management of who needs a test this year, mail outs of kits, compliance recording etc. and it's easy to see a $100 cost per FIT test.
- Forums
- ASX - By Stock
- RHY
- New York Times article
New York Times article, page-13
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.005(7.46%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.2¢ | $19.21K | 297.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 126586 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 19092 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 110000 | 0.062 |
1 | 10000 | 0.061 |
1 | 33639 | 0.060 |
1 | 5000 | 0.056 |
2 | 19091 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 19092 | 2 |
0.067 | 97928 | 1 |
0.069 | 29999 | 1 |
0.070 | 1794 | 1 |
0.071 | 117305 | 2 |
Last trade - 14.58pm 30/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online